Last update 01 Nov 2024

Mundipharma Pty Ltd.

Subsidiary Company|
Australia
|
www.mundipharma.com.au

Overview

Tags

Nervous System Diseases
Immune System Diseases
Digestive System Disorders
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Immune System Diseases1
Nervous System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
DHFR(Dihydrofolate reductase)1
PGF2α(Prostaglandin F2 alpha)1
Opioid receptors1

Related

3
Drugs associated with Mundipharma Pty Ltd.
Naloxone Hydrochloride/Oxycodone Hydrochloride
Target
Opioid receptors
Mechanism
Opioid receptors agonists
Active Org.
Mundipharma Pty Ltd. [+2]
Originator Org.
Purdue Pharma LPPurdue Pharma LP
Active Indication
Pain [+4]
Inactive Indication
Chronic Pain [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
AU
First Approval Date12 May 2010
Pralatrexate
Target
DHFR
Mechanism
DHFR inhibitors
Active Org.
Mundipharma International Ltd.Mundipharma International Ltd. [+10]
Originator Org.
Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center
Active Indication
Peripheral T-Cell Lymphoma
Inactive Indication
Adenocarcinoma of Esophagus [+26]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date24 Sep 2009
Tafluprost
Target
PGF2α
Mechanism
PGF2α agonists
Active Org.
Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd. [+3]
Originator Org.
Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd. [+1]
Active Indication
Glaucoma, Open-Angle [+1]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date16 Dec 2008
5
Clinical Trials associated with Mundipharma Pty Ltd.
ACTRN12622001478707 / Not yet recruitingNot ApplicableIIT
A multi-centre, randomised phase 2 clinical trial of early salvage radiotherapy versus surveillance on the incidence of biochemical recurrence after radical prostatectomy for men with prostate cancer, incorporating clinical and imaging-based risk stratification.
NCT01961271 / CompletedPhase 4
Multicentre Study To Evaluate Efficacy And Safety Of Buprenorphine Transdermal Patch (Norspan) In Chronic Non-Malignant Pain Of Moderate To Severe Intensity Due To Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain And Joint / Muscle Pain, When Opioid Is Needed For Analgesia
ACTRN12609000647235 / Active, not recruitingPhase 3
A Multicentre, Randomised, Double-Blind, Parallel Group Comparison Of The Efficacy And Safety Of Transdermal Buprenorphine (Norspan'registered trade mark' Buprenorphine transdermal system [BTDS]) And Placebo In Patients With Diabetic Peripheral Neuropathic Pain.
100 Clinical Results associated with Mundipharma Pty Ltd.
Login to view more data
0 Patents (Medical) associated with Mundipharma Pty Ltd.
Login to view more data
100 Deals associated with Mundipharma Pty Ltd.
Login to view more data
100 Translational Medicine associated with Mundipharma Pty Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
3
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free